PowerPoint Presentation

CARING FOOT SAVING LIFE. Innovation way to keep diabetic foot on the way Unique medicine to treat diabetic foot ulcers systemically and topically in the world..

Advanced Diabetic Foot Ulcer Treatment Effective Solutions for Healing & Prevention.

Before introduce our innovative and unique product we have to know what is the “DFU” Diabetic Foot Ulcer and its complications and negative outcomes to the diabetic patients..

Before introduce our innovative and unique product we have to know what is the “DFU” Diabetic Foot Ulcer and its complications and negative outcomes to the diabetic patients..

So, At Bochéry LAB ESTHÉTIQUE understand the challenges faced by diabetic patients with foot ulcers. That's why we've developed an advanced Diabetic Foot Ulcer treatment product designed to promote healing and prevent complications. (Not only topically but also systemically as well)..

Research results indicate that is the most effective medication for the condition and enhances the healing process by improving the blood circulation in the ulcer and has no side effects. LYTONIC ™ available in two pharmaceutical forms (Gel & Capsules) to work topically and systemically. LYTONIC ™.

Welcome to the future of Diabetic Foot Ulcer care with LYTONIC Plus™. Our revolutionary capsules offer an effective solution for Diabetic Foot Ulcer, promoting healing and preventing complications LYTONIC Plus™: Advanced Diabetic Foot Ulcer Care Capsules for Enhanced Healing & Prevention complications..

LYTONIC Plus™ capsules are a powerful oral supplement designed to support blood circulation, promote antioxidant action, and enhance the body's natural healing processes. These benefits are vital for diabetic foot ulcer (DFU) treatment and overall skin repair..

LYTONIC Plus™: Mechanism of Action. • Improves blood circulation to the affected area. • Enhances tissue regeneration and cellular repair. • Reduces oxidative stress and inflammation, accelerating healing. • Promotes overall systemic health to support DFU treatment..

Aqua (Water), Glycerin, Carbomer, Melilotus Officinalis Extract, Disodium Acetyl Glucosamine Phosphate, Carboxypolymethylene, Caffeyl Glucoside, Sodium Hyaluronate, Copper Tripeptide-1, Sodium Hydroxide, Methylpropanediol, Caprylyl Glycol, Phenylpropanol..

Mode of action: it`s working through its antioxidant properties, improving blood circulation and strengthening the lymphatic system, it causes the removal of dead tissue in the affected area..

Our revolutionary offers an effective solution for Diabetic Foot Ulcer, promoting healing and preventing complications, Innovative Revitalizing Nano Complex for Revitalizing, Repairing, Deep Hydrating of Skin, Cells Oxygenating, Antioxidant, Skin Detox. MelilotusOfficinalis Dried Extract: Enhanced Lymphatic Drainage & Microcirculation. Copper Tripeptide: Skin Repairing & Restructuring. Phosphorylated Amino-Sugar: Skin Repairing & Remodeling. Glycosylated Polyphenols: Cells Oxygenating, Skin Detoxification. Hyaluronic Acid: Deep Hydrating & Anti-irritant effect..

LYTONIC GEL Hydrating o' Sk Ox-nenat*'g. Detox. LYTON'C.

-Enhanced Efficacy: The internal and external application provides complete care, addressing both systemic and localized factors of DFU. -Integrated Therapy: Capsules improve circulation and reduce internal inflammation, while the gel soothes, hydrates, and protects the skin. -Rapid Recovery: Together, they accelerate healing, reduce infection risk, and support overall foot health..

Synergistic Effects of LYTONIC Plus™ & LYTONIC Gel ™.

References: The Effect of Angipars on Diabetic Neuropathy in STZ-Induced Diabetic Male Rats: A Study on Behavioral, Electrophysiological, Sciatic Histological and Ultrastructural Indices 1. Armstrong DG, et al. Diabetic Foot Ulcer and their recurrence. New England Journal of Medicine. 2017; 376:2367-75. 2. International best practice guidelines: wound management in Diabetic Foot Ulcer . Wounds International, 2013. 3. Ousey K, Chadwick P, Jawien A, Tariq G, Nair HKR, Lázaro-Martínez JL, Sandy-Hodgetts K, et al. Identifying and treating foot ulcers in patients with diabetes: saving feet, legs and lives. Journal of Wound Care 2018; 27(5 Suppl 5b) 4. American Diabetes Association. Diabetes Care 2018 Jan; 41(Supplement 1): S38-S50 5. World Union of Wound Healing Societies (WUWHS), Florence Congress, Position Document. Local management of Diabetic Foot Ulcer . Wounds International, 2016. 6. White R. A multinational survey of the assessment of pain when removing dressings. Wounds UK 2008;4(1):14-22. 7. White R, et al. Evidence for atraumatic soft silicone wound dressing use. Wounds UK 2005;1(3):104-109. 8. Zillmer R, Agren MS, Gottrup F, Karlsmark T. Biophysical effects of repetitive removal of adhesive dressings on peri-ulcer skin. Journal of Wound Care 2006;15(5):187-191. 9. Waring M, Biefeldt S, Matzold KP, Butcher M. An evaluation of the skin stripping of wound dressing adhesives. Journal of Wound Care 2011;20(9):412-422. 10. Upton D. et al. Pain and stress as contributors to delayed wound healing. Wound Practice and Research, 2010..

Case Report for LYTONIC Plus & Gel. Effective Treatment for Diabetic Foot Ulcer with Edema.

Healing Progress with LYTONIC Plus & Gel. Documented 8 Days Albania Case.

Introduction. One of the major complications of diabetes is diabetic ulcer, primarily affecting the foot and often leading to amputation. Poor control of blood glucose is a key factor, with complications such as infection and gangrene. (LYTONIC Plus & Gel) has been introduced as a novel treatment option, showing significant efficacy in improving venous circulation, reducing inflammation, and promoting healing..

Patient Information. Name: Belerina Age: 65 years Location: Albania Diagnosis: Diabetic Foot Ulcer with Edema Date: 27th July, 2024.

Case Description. Initial Presentation: 1- Condition: Diabetic ulcer with edema in the little toe of the left foot. 2- Symptoms: Severe swelling, pain, and ulceration. 3- Medical History: Long-standing diabetes with poor glycemic control..

Treatment Protocol. 1. Medication: LYTONIC Plus and Gel 2. Dosage: Plus twice daily, Gel applied twice daily 3. Other Treatments: Regular wound cleaning, antibiotics, antifungal medication.

Day 3: Initial Observations. Observations and Results Day3 (Initial Administration) “30th July,2024 Symptoms: Significant edema in the affected areas, visible ulceration. Action Taken: Administration of LYTONIC Plus and Gel, regular wound cleaning, antibiotics, and antifungal medication..

Day 15: Progress. Lymphatic Activity: Beginning signs of lymphatic activity around the affected areas. Revascularization: Initial signs of revascularization observed in the little toe in foot. Edema Reduction: Continued decrease in swelling; noticeable improvement in the little toe in foot. Ulcer Condition: Ulcer symptoms starting to reduce, slight decrease in exudate..

Day 30: Continued Progress. 1. Lymphatic Activity: Increased lymphatic drainage around the affected fingers and toe. 2. Revascularization: Continued improvement in blood flow to the little toe. 3. Edema Reduction: Significant reduction in swelling. 4. Ulcer Condition: Ulcers starting to heal; reduction in size and improved tissue appearance..

Day 60: Final Results. 1- Overall Condition: Marked improvement in the patient’s condition. 2- Lymphatic Activity: Strong lymphatic response aiding in the reduction of edema. 3- Revascularization: Noticeable revascularization of both the little toe . 4- Ulcer Condition: Continued reduction in ulcer size, less exudate, and healthier tissue appearance..

Summary of Findings. • LYTONIC Plus and Gel are effective in reducing edema, promoting revascularization, and initiating lymphatic activity. • Significant improvement in swelling reduction and ulcer healing observed within 8 days. • Promising therapeutic effect for diabetic ulcers with edema..

Conclusion. The medication of LYTONIC Plus and Gel, combined with regular wound cleaning, antibiotics, and antifungal medication, has demonstrated a promising therapeutic effect in managing diabetic ulcers. Further treatment is recommended for full recovery..

Healing Progress with LYTONIC Plus & Gel. Documented Over 24 Days Kuwait Case.

Female Patient in Her Forties. Details: The patient underwent an abdominoplasty procedure six months ago, involving the removal of excess skin in the lower abdominal region. However, a significant portion of the surgical wound failed to heal properly. Over time, the wound has exhibited signs of infection, inflammation, and necrosis, with no significant improvement despite the elapsed time. Comprehensive evaluation and management recommendations are requested to address the chronic non-healing wound and associated complications..

Day 21: Initial Condition. The wound shows significant inflammation, redness, and an open surface. Initial care involves starting LYTONIC Plus capsules (21/day) and applying LYTONIC Gel externally twice daily..

Day 45: Noticeable Healing. Inflammation reduced significantly. Granulation tissue begins to form, and the wound edges show signs of contraction. Daily care with LYTONIC Gel continues to promote tissue regeneration..

Day 60: Advanced Healing Stage. The wound has almost fully healed. Minimal scarring observed, with epithelialization completed. LYTONIC therapy contributed to improved healing time and tissue quality..

Day 72: Advanced Healing Stage. [image] LYTONIC BE LYTONIC PLUS.

Day 90: Advanced Healing Stage. [image] LYTONIC BE LYTONIC PLUS Beqhéry -.

Effective Healing with LYTONIC Plus & LYTONIC Gel.

Baseline Observation Date : 24/11/2024. Description of the condition before treatment: Presence of wounds, discoloration, and inflammation. Visual Reference: Image showing the initial condition..

Application of LYTONIC. Day 1 to Day 4: LYTONIC Plus: 1 capsule per day orally. LYTONIC Gel: Applied twice daily to the affected area. Additional supportive care: Cleaning and dressing..

Progress Observed. Reduction in inflammation and discoloration. Visible improvement in wound size and appearance. Faster healing compared to conventional treatment. Visual Reference: Annotated image showing progress..

Why LYTONIC?. Accelerates wound healing. Combines systemic and topical treatment. Anti-inflammatory and antioxidant properties. Clinically tested and safe for diabetic patients..

Key Takeaways. Significant progress observed after 4 days of LYTONIC treatment. Comprehensive approach for managing diabetic foot ulcers. Effective solution for wound care and healing..

References: The Effect of Angipars on Diabetic Neuropathy in STZ-Induced Diabetic Male Rats: A Study on Behavioral, Electrophysiological, Sciatic Histological and Ultrastructural Indices 1. Armstrong DG, et al. Diabetic Foot Ulcer and their recurrence. New England Journal of Medicine. 2017; 376:2367-75. 2. International best practice guidelines: wound management in Diabetic Foot Ulcer . Wounds International, 2013. 3. Ousey K, Chadwick P, Jawien A, Tariq G, Nair HKR, Lázaro-Martínez JL, Sandy-Hodgetts K, et al. Identifying and treating foot ulcers in patients with diabetes: saving feet, legs and lives. Journal of Wound Care 2018; 27(5 Suppl 5b) 4. American Diabetes Association. Diabetes Care 2018 Jan; 41(Supplement 1): S38-S50 5. World Union of Wound Healing Societies (WUWHS), Florence Congress, Position Document. Local management of Diabetic Foot Ulcer . Wounds International, 2016. 6. White R. A multinational survey of the assessment of pain when removing dressings. Wounds UK 2008;4(1):14-22. 7. White R, et al. Evidence for atraumatic soft silicone wound dressing use. Wounds UK 2005;1(3):104-109. 8. Zillmer R, Agren MS, Gottrup F, Karlsmark T. Biophysical effects of repetitive removal of adhesive dressings on peri-ulcer skin. Journal of Wound Care 2006;15(5):187-191. 9. Waring M, Biefeldt S, Matzold KP, Butcher M. An evaluation of the skin stripping of wound dressing adhesives. Journal of Wound Care 2011;20(9):412-422. 10. Upton D. et al. Pain and stress as contributors to delayed wound healing. Wound Practice and Research, 2010..